Filtering

Page: () 1 2 3 4 5 6 7 8 9 10 ()
ECCO'18 ViennaOP009: A combination of clinical, serological and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based study.
Year: 2018
Source: ECCO'18 Vienna
Authors: Sarter Hélène
Files: 1
ECCO'17 BarcelonaOP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn’s Disease: 52-week results of a phase III randomised controlled trial
Year: 2017
Source: ECCO'17 Barcelona
Authors: Panés J.
Stem cell transplantation/therapy
Files: 1
ECCO'17 BarcelonaOP010: Long term efficacy and safety of Ustekinumab for Crohn’s Disease: Results from IM-UNITI long-term extension through 2 years
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Ustekinumab
Files: 1
ECCO'18 ViennaOP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: Al Bakir Ibrahim
Files: 1
ECCO'17 BarcelonaOP011:Etrolizumab treatment leads to early improvement in symptoms and inflammatory biomarkers in anti-TNF-refractory patients in the open-label induction cohort of the phase 3 HICKORY study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Peyrin-Biroulet L.
Etrolizumab
Files: 1
ECCO'17 BarcelonaOP012: Perioperative use of vedolizumab is not associated with short-term postoperative infectious complications in patients with Ulcerative Colitis undergoing (procto)colectomy with ileal pouch- anal anastomosis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Ferrante M.
Ulcerative colitis, Ileo anal pouch procedure, Post operative complications, Post operative medical management, Vedolizumab
Files: 1
ECCO'17 BarcelonaOP013: Disease management and outcomes of patients with Crohn’s Disease at high risk of recurrence. Results from PRACTICROHN study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Iborra M.
Colonscopy, Ileo caecal resection, Post operative complications, Post operative medical management, Thiopurines ( AZA / MP )
Files: 1
ECCO'18 ViennaOP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn's Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Sazonovs Aleksejs
ECCO'18 ViennaOP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for Inflammatory Bowel Disease and irritable bowel syndrome
Year: 2018
Source: ECCO'18 Vienna
Authors: Vich Vila Arnau
Files: 1
ECCO'17 BarcelonaOP014: Histological remission is predictive of improved clinical outcomes in patients with Ulcerative Colitis: Results from the TOUCHSTONE OLE
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Ozanimod, Histological remission
Files: 1
ECCO'17 BarcelonaOP015: Cost-effectiveness of laparoscopic ileocecal resection versus infliximab treatment of terminal ileitis in Crohn’s Disease: THE LIR!C TRIAL
Year: 2017
Source: ECCO'17 Barcelona
Authors: de Groof J.
Crohn's disease, Ileo caecal resection, Laparoscopic surgery, Infliximab
Files: 1
ECCO'18 ViennaOP016: Need for primary abdominal surgery, but not repeated surgery, has decreased – a nationwide study of temporal trends in Crohn surgery in Sweden 1990-2014
Year: 2018
Source: ECCO'18 Vienna
Authors: Kalman Disa
Files: 1
ECCO'17 BarcelonaOP016: Potential role of bile acid receptor FXR in microscopic colitis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Palmela C.
Histology, Microscopic colitis
Files: 1
ECCO'17 BarcelonaOP017: Telemedicine enables a safe shift from examination room based care to personalised care for Inflammatory Bowel Disease: A pragmatic randomised multicenter trial with myIBDcoach
Year: 2017
Source: ECCO'17 Barcelona
Authors: de Jong M.
Disease activity Indices, Patient reported outcomes, Quality of life, IBD nurse
Files: 1
ECCO'18 ViennaOP017: Transanal minimally-invasive proctectomy with ileal pouch anal anastomosis (Ta-IPAA) in patients with Ulcerative Colitis: A cohort study from the TaTME international database
Year: 2018
Source: ECCO'18 Vienna
Authors: Pellino Gianluca
Files: 1
ECCO'18 ViennaOP018: High-Fat diet and inflammation drive intestinal fibrosis enhancing epithelial-mesenchymal transition through the activation of S1P3 signaling
Year: 2018
Source: ECCO'18 Vienna
Authors: Elangovan Sudharshan
Files: 1
ECCO'17 BarcelonaOP018: Optimal anti-TNF stop week during pregnancy depends on anti-TNF type
Year: 2017
Source: ECCO'17 Barcelona
Authors: Kanis S.
Anti TNF drug levels, Anti TNF agents, IBD in pregnancy
Files: 1
ECCO'17 BarcelonaOP019: Correlation of clinical and endoscopic outcomes in patients with active Crohn’s Disease treated with mongersen (GED- 0301)
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Mongersen
Files: 1
ECCO'18 ViennaOP019: In Faecal Microbiota Transplantation (FMT) for Ulcerative Colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short chain fatty acid production are associated with remission (FOCUS study)
Year: 2018
Source: ECCO'18 Vienna
Authors: Paramsothy Sudarshan
Files: 1
ECCO'17 BarcelonaOP020: Recent anti-TNF exposure predicts lower vedolizumab trough concentrations in patients with Crohn Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Gils A.
Therapeutic drug monitoring, Pharmacokinetics, Vedolizumab
Files: 1
Page: () 1 2 3 4 5 6 7 8 9 10 ()